There’s an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on August 30, National Health Investors, Inc.’s Director, James R. Jobe, invested $51,398.20 into 1,000 shares of NHI, for a cost per share of $51.40. Bargain hunters tend to pay particular attention to insider buys like this one, because presumably the only reason an insider would take their hard-earned cash and use it to buy stock of their company in the open market, is that they expect to make money.
In trading on Tuesday, bargain hunters could buy shares of National Health Investors, Inc. (Symbol: NHI) and achieve a cost basis even cheaper than Jobe, with shares changing hands as low as $51.31 per share. National Health Investors, Inc. shares are currently trading down about 0.8% on the day. The chart below shows the one year performance of NHI shares, versus its 200 day moving average:
Looking at the chart above, NHI’s low point in its 52 week range is $47.54 per share, with $67.12 as the 52 week high point — that compares with a last trade of $51.25. By comparison, below is a table showing the prices at which NHI insider buying was recorded over the last six months:
Purchased
Insider
Title
Shares
Price/Share
Value
08/30/2023
James R. Jobe
Director
1,000
$51.40
$51,398.20
The current annualized dividend paid by National Health Investors, Inc. is $3.6/share, currently paid in quarterly installments, and its most recent dividend has an upcoming ex-date of 09/28/2023. Below is a long-term dividend history chart for NHI, which can be of good help in judging whether the most recent dividend with approx. 7.0% annualized yield is likely to continue.
Click here to find out which 9 other dividend bargains you can buy cheaper than insiders »
Also see:
Cheap Energy Stocks Paying Dividends
Top Ten Hedge Funds Holding ALAC
AWR Stock Predictions
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
